Honz Pharmaceutical Co., Ltd.

SZSE:300086 Stock Report

Market Cap: CN¥1.7b

Honz Pharmaceutical Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Jiangtao Hong

Chief executive officer


Total compensation

CEO salary percentagen/a
CEO tenure4.5yrs
CEO ownership0.5%
Management average tenureno data
Board average tenure4.5yrs

Recent management updates

Recent updates


Jiangtao Hong (54 yo)





Mr. Jiangtao Hong has been President at Honz Pharmaceutical Co., Ltd. since December 19, 2019 and served as its Vice President.

Board Members

Liping Hong
Vice Chairman & VP16.5yrsCN¥339.50k0.17%
CN¥ 2.8m
Jiangyou Hong
CN¥ 28.3m
Qinghe Wu
Independent Director1.5yrsCN¥3.80kno data
Huan Xue Zheng
Independent Director1.5yrsCN¥3.80kno data
Youquan Li
Non-Independent Director4.5yrsCN¥180.00kno data
Dongxiong Hong
Director1.5yrsno datano data
Chunying Wang
Non-Employee Supervisor4.5yrsno data0.00011%
CN¥ 1.8k
Jicheng Zhang
Independent Director4.5yrsCN¥90.00kno data
Mengke Sun
Non-Employee Supervisor1.5yrsno datano data


Average Tenure


Average Age

Experienced Board: 300086's board of directors are considered experienced (4.5 years average tenure).

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.